TY - JOUR
KW - Animals
KW - Antitubercular Agents
KW - Aspergillosis
KW - Candidiasis
KW - Chloroquine
KW - Cricetinae
KW - Disease Models, Animal
KW - Drug Resistance, Microbial
KW - Drug Synergism
KW - Escherichia coli Infections
KW - Female
KW - Isoniazid
KW - Klebsiella Infections
KW - leprosy
KW - Listeriosis
KW - Malaria
KW - Mice
KW - Mycobacterium Infections
KW - Mycobacterium tuberculosis
KW - Mycoses
KW - Nitrofurans
KW - Nocardia Infections
KW - Oils
KW - Phenazines
KW - Pneumococcal Infections
KW - Rats
KW - Staphylococcal Infections
KW - Stimulation, Chemical
KW - Streptococcal Infections
KW - Surface-Active Agents
KW - Time Factors
KW - Tinea
KW - Toxoplasmosis, Animal
KW - Trypanosomiasis
KW - Tuberculosis
AU - Vischer W A
BT - Arzneimittel-Forschung
C1 - http://www.ncbi.nlm.nih.gov/pubmed/4988610?dopt=Abstract
DA - 1970 May
IS - 5
J2 - Arzneimittelforschung
LA - eng
PY - 1970
SP - 714
EP - 23
T2 - Arzneimittel-Forschung
TI - Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663).
VL - 20
SN - 0004-4172
ER -